Structure of Axitinib CAS 319460-85-0

Axitinib CAS 319460-85-0

Identification
Properties
Safety Data
Specifications & Other Information
Links

Identification

CAS Number

319460-85-0

Name

Axitinib

Key intermediates of the Axitinib

CAS:886230-77-9;Name:(E)-6-iodo-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
CAS:885126-35-2;Name:N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide
CAS:86230-76-8
CAS:20054-45-9;Name:N-methyl-2-sulfanylbenzamide

Synonyms

319460-85-0 [RN]
8720
axitinib [Spanish] [INN]
axitinib [French] [INN]
Axitinib [INN] [USAN] [Wiki]
axitinibum [Latin] [INN]
Benzamide, N-methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-
Benzamide, N-methyl-2-[[3-[(E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]- [ACD/Index Name]
C9LVQ0YUXG
N-Methyl-2-({3-[(E)-2-(2-pyridinyl)vinyl]-1H-indazol-6-yl}sulfanyl)benzamid [German] [ACD/IUPAC Name]
N-Methyl-2-({3-[(E)-2-(2-pyridinyl)vinyl]-1H-indazol-6-yl}sulfanyl)benzamide [ACD/IUPAC Name]
N-Méthyl-2-({3-[(E)-2-(2-pyridinyl)vinyl]-1H-indazol-6-yl}sulfanyl)benzamide [French] [ACD/IUPAC Name]
N-methyl-2-({3-[(E)-2-(pyridin-2-yl)ethenyl]-1H-indazol-6-yl}sulfanyl)benzamide
N-Methyl-2-({3-[(E)-2-(pyridin-2-yl)vinyl]-1H-indazol-6-yl}sulfanyl)benzamide
N-methyl-2-[[3-[2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide
UNII-C9LVQ0YUXG
акситиниб [Russian] [INN]
أكسيتينيب [Arabic] [INN]
阿昔替尼 [Chinese] [INN]
(E)-N-methyl-2-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide
(E)-N-methyl-2-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-ylthio)benzamide
(trans-4-Methylpyrrolidin-3-yl)methanol
[319460-85-0]
{2-[3-((1E)-2-(2-pyridyl)vinyl)(1H-indazol-6-ylthio)]phenyl}-N-methylcarboxamide
319463-51-9 [RN]
70356-09-1 [RN]
945723-36-4 [RN]
AG 013736|AG-013736|AG013736|Inlyta®
AG013736
AG-013736; AG 013736; AG013736
AG13736
Avobenzone [INN] [USAN] [USP] [Wiki]
AXI
Axitinib (AG 013736)
Axitinib [USAN]
axitinibum
Axtintib
Benzamide, N-methyl-2-((3-((1E)-2-(2-pyridinyl)ethenyl)-1H-indazo)-6-yl)thio)-
Inlyta
Inlyta®
MFCD09837898 [MDL number]
MFCD14708210
N-Methyl-[[3[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-benzamide
N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-i ndazol-6-yl)sulfanyl)benzamide
N-Methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide
N-methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-benzamide
N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide
N-methyl-2-[[3-[(E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide
N-methyl-2-[[3-[(E)-2-(2-pyridyl)vinyl]-1H-indazol-6-yl]sulfanyl]benzamide
N-methyl-2-[[3-[(E)-2-(2-pyridyl)vinyl]-1H-indazol-6-yl]thio]benzamide
N-Methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide
N-methyl-2-[[3-[(Z)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide
N-Methyl-2-[3-(2-pyridin-2-yl-vinyl)-1H-indazol-6-ylsulfanyl]-benzamide
N-methyl-2-3-(1E)-2-(2-pyridinyl)ethenyl-1H-indazol-6-ylthio-benzamide
S1005
UNII:C9LVQ0YUXG

Molecular Structure

Structure of Axitinib CAS 319460-85-0

Structure of Axitinib CAS 319460-85-0

SMILES

CNC(=O)c1ccccc1Sc2ccc3c(c2)[nH]nc3/C=C/c4ccccn4

StdInChI

InChI=1S/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H,23,27)(H,25,26)/b12-9+

StdInChIKey

RITAVMQDGBJQJZ-FMIVXFBMSA-N

Molecular Formula

C22H18N4OS

Molecular Weight

386.47

MDL Number

MFCD09837898

Appearance

Pale yellow powder or off-white powder

Safety Data

Symbol

exclamation-mark-jpgexclamation-mark-jpgHS07, GHS09

Signal Word

Warning

Hazard Statements

H302-H400

Precautionary Statements

P273

RIDADR

UN 3077 9 / PGIII

WGK Germany

3

Specifications and Other Information of Our Axitinib CAS 319460-85-0

Standard

Enterprise standard

Identification Methods

HNMR,HPLC

Purity

99%min

Loss on Drying

≤1.0%

Residue on Ignition

≤ 1.0%

Single max Impurity

≤ 0.3%

Total Impurities

≤ 1.0%

Package

According to customer requirements to packaging

Storage

Under the room temperature and away from light

Application

Commonly used for the treatment of kidney cancer.

Links

This product is developed by our sub R&D company Caming Pharmaceutical Ltd, and please click the link below for details.
http://www.caming.com/axitinib-cas-319460-85-0/

This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://www.watson-int.com/axitinib-cas-319460-85-0/